CoreCivic reported Q1 2026 earnings after the close on Wednesday, posting FFO of $0.65 against a $0.55 consensus estimate and revenue of $614.7 million versus the $604.5 million expected. Management lifted full-year FFO guidance to $2.58–$2.68 from the prior $2.54–$2.64 range. The stock had already fallen 5.6% in the week leading into the print — a market telling a different story than the numbers did.
The price action going in was the clearest warning sign. CXW closed at $19.42 on Tuesday, down 3.6% on the day and off 5.3% over the prior month. Whatever short-side pressure built through mid-April — short interest touched 2.7 million shares around April 16 — has since reversed. By Wednesday evening, estimated short interest had pulled back to roughly 2.4 million shares, about 2.3% of the free float, down 11% from its one-month peak. That is a small and declining short position. The borrow market confirms it: availability is extraordinarily loose, and the cost to borrow has roughly doubled over the past month but remains trivial at 0.47% — well under the threshold that signals any genuine squeeze setup. The lending market is not the story here.
Options positioning reinforces the bull-leaning tone, and it stands in contrast to the week's price weakness. The put/call ratio has been trending lower, now running at 0.14 — near its 52-week low of 0.12 and well below the 20-day average of 0.17. That is call-heavy positioning heading into an earnings beat. Whether that reflects conviction or positioning that still needs to be validated by the post-earnings tape will be worth watching in Thursday's session.
The analyst consensus offers modest but uniform support. Four buy-rated analysts cover the name. In March, Benchmark initiated with a Buy and a $28 target — at the time about 40% above the then-current price, and still roughly 44% above where the stock closed this week. Jones Trading has held its $30 Buy target consistently through multiple check-ins. The mean price target of $29.80 implies substantial upside from current levels, though the gap between $19.42 and that target is wide enough to suggest analysts see the discount as an opportunity. The PE multiple has compressed to about 11x on trailing earnings, with EV/EBITDA around 7x and ticking lower over the past 30 days — cheap territory for an operator with long-dated government contracts and a raised guidance range.
The insider tape muddies that picture somewhat. On February 20, CEO Damon Hininger sold 133,674 shares at $16.74, and the President/COO and a senior EVP made similar-sized sales on the same day. Those transactions came alongside stock awards to other officers — likely a vesting-and-sell-to-cover pattern around the annual grant cycle rather than a bearish signal per se. More recently, General Counsel Cole Carter sold 12,500 shares in each of March, April, and May, a steady and mechanical-looking pattern. The net 90-day insider flow is positive at roughly 381,000 shares, reflecting the awards component. None of this is alarming, but the CEO sale at $16.74 — below the current price — removes one potential narrative about management loading up on a discount.
The key variable from here is how the market absorbs the earnings beat in Thursday's first full trading session. The most direct peer, GEO Group, also reported this week and is down about 2.4% on the week, holding up somewhat better than CXW. With short interest light, borrow conditions loose, and options leaning bullish, the setup heading into the call is structurally positive — but the stock's inability to hold gains through the week before a clean beat leaves the question of whether the guidance raise is enough to shift the tape.
See the live data behind this article on ORTEX.
Open CXW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
